Clinical Trial Update: A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial update on CD20-targeted CAR-T therapy for B cell malignancies (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• CD20-targeted CAR-T therapy

Snippet

Sponsor: Southwest Hospital, China | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN